X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR)

CUSIP: 98420X103

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
7,938,059
Total 13F shares
99,822,228
Share change
-7,821,283
Total reported value
$73,237,480
Put/Call ratio
20%
Price per share
$0.73
Number of holders
89
Value change
-$4,976,749
Number of buys
35
Number of sells
40

Quarterly Holders Quick Answers

What is CUSIP 98420X103?
CUSIP 98420X103 identifies XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) as of Q4 2024

As of 31 Dec 2024, X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) was held by 89 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 99,822,228 shares. The largest 10 holders included Bain Capital Life Sciences Investors, LLC, NEA Management Company, LLC, BlackRock, Inc., VANGUARD GROUP INC, ACORN CAPITAL ADVISORS, LLC, ORBIMED ADVISORS LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, AXA S.A., and STATE STREET CORP. This page lists 89 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.